// App-Quantinova.ai

M1006 2016 AHA : ABCA1 Agonist Treatment of ApoE4 Driven Alzheimer-s Disease, Effects on Serum ApoE Distribution, Brain Phenotype and Cognition

Researchers

Presenter

  • Anat Boehm-Cagan

Principal Investigators

  • Anat Boehm-Cagan

  • John K Bielicki

  • Anouar Hafiane

  • Jacques Genest

  • Salman Azhar

  • Daniel Michaelson

Medical Centers

  • VA Palo Alto Health Care System, Stanford Univ Sch of Med, Stanford, CA

  • McGill Univ Health Ctr/Royal Victoria Hosp, Montgreal, QC

  • Lawrence Berkeley National Lab, Berkeley, CA

  • Tel-Aviv University, Tel Aviv, Israel.

  • McGill Univ Health Ctr/Royal Victoria Hosp, Montgreal, QC

  • Tel Aviv Univ, Israel, Tel Aviv, Israel

  • Inc., San Ramon, CA

Locations

  • United States

  • Canada

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Apolipoprotein E

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved